Cholera vaccine program monitoring and household tracking
Part of Infections clinical trials.
This study monitors how cholera vaccination efforts are working in areas where cholera is common. It checks people who come to cholera treatment centers and certain household contacts to see who has cholera and follows them for surveillance.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must go to a selected cholera treatment center or unit during the study
- You must meet the study’s definition of a possible cholera case (as determined by the team)
- You must agree to take part (or a child 8–17 must assent, with guardian consent)
- If you are not a patient, you may be included as a household contact of an eligible person
- For household contacts, the head of the household must agree to participate for the household
- You must accept the study testing/monitoring activities if asked
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a 7-day preventive intervention for cholera-like diarrhea in households without running water. It may help reduce illness spread and protect young children when families lack safe water at home.
This trial provides oral cholera vaccine and water treatment to households near someone with cholera to stop the disease from spreading. It may help protect your family if you live close to a cholera case.
This study looks at how well the cholera vaccine and past infections protect people from getting cholera. It may help researchers understand who stays protected and for how long.
This trial tests a 7-day hospital-based program to help patients with diarrhea who lack running water at home. It aims to prevent the spread of cholera and improve recovery.
This trial offers a 7-day program to help cholera patients who don't have running water at home. It provides tools and guidance on water, sanitation, and hygiene to stop cholera from spreading.
This trial tests a new cholera vaccine in healthy people ages 1 to 45. It aims to see if the vaccine is safe and creates a good immune response.
Hear when a new Cholera trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.